TSANZ SIG Orals: Asthma & Allergy 1
Tracks
TSANZ Orals
Saturday, March 22, 2025 |
3:30 PM - 5:00 PM |
E1 |
Speaker
Dr Mike Forrester
Paediatrician And Senior Research Fellow
Deakin University
The National Sustainable Asthma Care Roadmap – Roundtable Report
3:30 PM - 3:45 PMBiography
Mike is a paediatrician and a Senior Research Fellow with The Institute for Health Transformation at Deakin University, focussing on understanding the environmental co-benefits of high-value and environmentally sustainable healthcare delivery. Mike is also the Victorian Chair of Doctors for the Environment Australia, advocating for 'One Health' / 'Health in all policies'.
Dr Michael Fricker
Research Fellow
University of Newcastle
Differential impact of IL5 pathway biologics on IL5R-expressing mast cell progenitors in severe asthma
3:45 PM - 4:00 PMBiography
Dr Fricker leads a research group at University of Newcastle and HMRI investigating inflammatory mechanisms, biomarkers and treatment options for obstructive airways diseases.
Prof David Langton
Director, Thoracic Medicine
Peninsula Health
Real-world study of anti-IL5 biologicals five years post initiation
4:00 PM - 4:15 PMBiography
Prof David Langton is a senior respiratory physician in Melbourne with a long held interest in asthma research
Prof John Upham
Professor
University of Queensland
Systematic corticosteroid increases healthcare costs in Australian patients with asthma
4:15 PM - 4:30 PMBiography
John is a respiratory physician and clinician scientist interested in immune dysfunction and the use of targeted therapies for asthma. He recently retired from the Princess Alexandra Hospital in Brisbane and is an Emeritus Professor with the University of Queensland.
Mr Alexander Roussos
Research Coordinator
Observational & Pragmatic Research Institute
Characteristics of asthma patients escalating from msICS/LABA to hsICS/LABA or msBDP/FF/G
4:30 PM - 4:45 PMBiography
Alexander is a Research Coordinator at Optimum Patient Care Australia, with expertise in real-life respiratory research. He has coordinated research projects using large primary care databases across the USA and Australia.
Prof Peter Wark
Professor
Alfred Health
Mepolizumab is not inferior to omalizumab, improving asthma control in severe allergic and eosinophilic asthma, a randomised, blinded, non-inferiority trial.
4:45 PM - 5:00 PMBiography
Peter Wark is the Director of Cystic Fibrosis and RES2, AIRMED, Alfred Health, Melbourne. He is a conjoint Professor of Medicine at Monash University. He holds an honorary position and is an adjunct Professor with the University of Newcastle and at the Hunter Medical Research Institute (HMRI).
Dr Alice Crawford
Respiratory Physician
Sir Charles Gairdner Hospital
Chairperson
Biography
Dr Alice Crawford is a respiratory consultant at the Sir Charles Gairdner Hospital and a researcher within the Airways Research Group. Her subspecialty expertise lies in asthma, inducible laryngeal obstruction, and dysfunctional breathing. Alice is an early career clinician-researcher currently completing her PhD at Curtin University.
Dr Richard Kim
Senior Lecturer
University of Technology Sydney
Chairperson
Biography
